Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
clinical trials
fda
life sciences
national blog main
3
×
boston top stories
eli lilly
indiana blog main
indiana top stories
national top stories
raleigh-durham blog main
raleigh-durham top stories
abbvie
aimmune therapeutics
alkermes
allergan
allergy
alprazolam
amgen
anaphylaxis
andrew oxtoby
boulder/denver blog main
boulder/denver top stories
buprenorphine
cariprazine
cgrp inhibitors
chronic migraine
colucid pharmaceuticals
daniel edelman
detroit blog main
detroit top stories
drug enforcement administration
eosinophilic esophagitis
europe
europe blog main
europe top stories
felipe jain
food allergy
immunotherapy
What
drug
3
×
fda
won
approval
friday
acute
addresses
agency
aimmune
alkermes
allergy
antipsychotic
approved
awarded
benefits
causes
caveats
commonly
condition
decades
designed
developed
effect
eli
favor
gain
giant
giving
immunotherapy
lasmiditan
late
lilly
lilly’s
medication
medicine
migraine
new
offer
oks
oral
Language
unset
3
×
Current search:
won���t
×
unset
×
biotech
×
" national blog main "
×
drug
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades